Lyra Health, a mental health service used by employees at companies like Uber and Morgan Stanley, raises a $235M Series F led by Dragoneer at a $5.85B valuation
Rebecca Torrence / FierceHealthcare :
Context & Ripple Effects
Lyra Health's arc runs from David Ebersman leaving the Facebook CFO seat to found the company in 2015 (its launch coverage) through a 'smart network' thesis in 2018 and a $75M Series C in March 2020, when it projected $100M in revenue for that year (the Series C round). The new $235M Series F at a $5.85B valuation, led by Dragoneer, marks the point where that trajectory puts it well clear of its closest funded rival.
That rival context matters: Modern Health raised a $51M Series C in December 2020 (Modern Health's Series C) and then $74M at a $1.17B valuation just two months later — meaning Lyra's new valuation is roughly five times its nearest comparable, both selling digital mental health care through employers.
First-order effects
- Dragoneer's $235M gives Lyra a decisive capital lead over Modern Health, whose entire raised total stood around $172M as of early 2021, letting it outspend on sales to large employers like Uber and Morgan Stanley.
Second-order effects
- Modern Health faces pressure to raise again or differentiate on price and product breadth, since enterprise buyers now see a clear valuation gap between the two platforms they evaluate for employee mental health benefits.
Third-order effects
- If the pattern holds, employer-sponsored mental health consolidates around a small set of venture-scaled networks, with mid-sized benefits vendors squeezed between Lyra's capital advantage and the procurement power of Fortune 500 HR buyers.
The trend: Employer-purchased mental health care is consolidating into heavily capitalized platform networks, with each funding round widening the gap between scale players and the rest of the vendor field.